Suppressing the Aberrant Transcriptional Functionality of EWS::FLI1 Oncoprotein by Designer polyQ Fusions with Its

Heng-Tong Duan1,2, Xiang-Le Zhang1,2, Lei-Lei Jiang1

  • 1Key Laboratory of RNA Innovation, Science and Engineering, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China.

Biomedicines
|February 27, 2026
PubMed

Insights

Researchers developed polyglutamine (polyQ) fusions to target the EWS::FLI1 oncoprotein in Ewing sarcoma. These fusions sequester EWS::FLI1, reducing its availability and altering downstream gene expression, offering a potential new therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Ewing sarcoma is driven by the EWS::FLI1 oncoprotein, a chimeric transcription factor causing aberrant gene regulation.
  • Targeting EWS::FLI1 is crucial for suppressing oncogenic progression, but its inhibition and clearance present significant challenges.
  • Current therapeutic strategies require novel approaches to directly address EWS::FLI1's oncogenic functions.

Purpose of the Study:

  • To investigate the efficacy of a polyglutamine (polyQ) fusion strategy for directly targeting and suppressing EWS::FLI1.
  • To design and construct novel polyQ fusion proteins capable of sequestering EWS::FLI1 within Ewing sarcoma cells.
  • To evaluate the impact of these polyQ fusions on EWS::FLI1 cellular availability and downstream gene expression.

Main Methods:

  • A polyglutamine (polyQ) fusion strategy was employed using polyQ-expanded ataxin-7 (Atx793Q-N172) as a template.
  • Three distinct polyQ fusion proteins (Atx793Q-N172-SYGQ1, Atx793Q-N172-SYGQ2, Atx793Q-N172-LCD) were designed and constructed.
  • Experiments involved supernatant/pellet fractionation and immunofluorescence imaging in A673 Ewing sarcoma cells.

Main Results:

  • The designed polyQ fusion proteins successfully co-precipitated and co-localized with endogenous EWS::FLI1 in A673 cells.
  • PolyQ fusions sequestered EWS::FLI1 into insoluble aggregates, significantly reducing its soluble cellular availability.
  • The Atx793Q-N172-LCD fusion notably altered EWS::FLI1 downstream gene expression, increasing P21 (CDKN1A) and decreasing c-Myc.

Conclusions:

  • Engineered polyQ fusions effectively entrap endogenous EWS::FLI1 protein into aggregates, reducing its functional soluble fraction in Ewing sarcoma cells.
  • This sequestration strategy presents a novel approach to inhibit the oncogenic activity of EWS::FLI1.
  • The study offers a potential alternative therapeutic avenue for Ewing sarcoma and other cancers driven by similar oncogenic proteins.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.9K
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
3.0K